Physician profile
Jamie E Bucher
NPI 1851170849
$1,270.61
in general payments reported to CMS, 2019-2025
14 companies · $639 in 2025
The $639 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $632 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,270.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $274.09 | 2024-2025 | Sprint Pns System |
| Boston Scientific Corporation | $152.24 | 2025 | Intracept |
| Nevro Corp. | $151.28 | 2024 | Senza |
| Abbvie INC. | $141.58 | 2024-2025 | |
| Medtronic, INC. | $135.20 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Vertos Medical, INC. | $112.07 | 2024 | Mild Device Kit |
| Depuy Synthes Sales INC. | $79.78 | 2025 | Monovisc, Orthovisc |
| Averitas Pharma INC. | $67.26 | 2024-2025 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $54.14 | 2025 | |
| Ibsa Pharma INC. | $29.33 | 2025 | Tirosint, Flector, Licart |
| Merz Pharmaceuticals, LLC | $22.35 | 2025 | Xeomin |
| Globus Medical, INC. | $20.39 | 2025 | Senza |
| Tonix Medicines, INC. | $15.74 | 2025 | Tonmya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.16 | 2025 | Relistor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Bucher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.